Artículos por temáticas

Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.

Bosco DA, LaVoie MJ, Petsko GA, Ringe D.

Cold Spring Harb Perspect Biol. 2011 Oct 1;3(10):a007500. doi: 10.1101/cshperspect.a007500. Review.

Psychogenic movement disorders and motor conversion: a roadmap for collaboration between neurology and psychiatry.

Kranick SM, Gorrindo T, Hallett M.

Psychosomatics. 2011 Mar-Apr;52(2):109-16. doi: 10.1016/j.psym.2010.12.017.

Movement disorders: Imaging differentiates progressive supranuclear palsy from Parkinson disease.

Jones N.

Nat Rev Neurol. 2011 Apr;7(4):186. doi: 10.1038/nrneurol.2011.31. No abstract available.

Towards remote evaluation of movement disorders via smartphones.

Kostikis N, Hristu-Varsakelis D, Arnaoutoglou M, Kotsavasiloglou C, Baloyiannis S.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5240-3. doi: 10.1109/IEMBS.2011.6091296.

Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience.

Vigliani MC, Honnorat J, Antoine JC, Vitaliani R, Giometto B, Psimaras D, Franchino F, Rossi C, Graus F; PNS EuroNetwork..

J Neurol. 2011 Nov;258(11):2058-68. doi: 10.1007/s00415-011-6074-1. Review.

Cognitive and psychiatric phenotypes of movement disorders in children: a systematic review.

Ben-Pazi H, Jaworowski S, Shalev RS.

Dev Med Child Neurol. 2011 Dec;53(12):1077-84. doi: 10.1111/j.1469-8749.2011.04134.x. Review.

Tardive movement disorders: a practical approach.

Saifee TA, Edwards MJ.

Pract Neurol. 2011 Dec;11(6):341-8. doi: 10.1136/practneurol-2011-000077. Review. No abstract available.

Reduced serum caeruloplasmin levels in non-wilsonian movement disorders.

Ling H, Bhidayasiri R.

Eur Neurol. 2011;66(3):123-7. doi: 10.1159/000330538.

Radiosurgery for movement disorders.

Barbarisi M, Pantelis E, Antypas C, Romanelli P.

Comput Aided Surg. 2011;16(3):101-11. doi: 10.3109/10929088.2011.569127.

[Drug induced movement disorders: role of antipsychotic drugs].

Damásio J, Carvalho S.

Acta Med Port. 2011 Dec;24 Suppl 4:915-22. Review. Portuguese.

Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies.

Dale RC, Yin K, Ding A, Merheb V, Varadkhar S, McKay D, Singh-Grewal D, Brilot F.

Dev Med Child Neurol. 2011 Jun;53(6):522-8. doi: 10.1111/j.1469-8749.2011.03922.x.

Movement Disorders, the journal, and movement disorders, the field?

Agid Y.

Mov Disord. 2011 May;26(6):937-8. doi: 10.1002/mds.23780. Review. No abstract available.

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.

Jankovic J, Clarence-Smith K.

Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149. Review.

Milestones in magnetic resonance imaging and transcranial sonography of movement disorders.

Berg D, Steinberger JD, Warren Olanow C, Naidich TP, Yousry TA.

Mov Disord. 2011 May;26(6):979-92. doi: 10.1002/mds.23766. Review. Erratum in: Mov Disord. 2011 Jun;26(7):1372.

[Deep brain stimulation in movement disorders: a Prague-center experience].

Urgosík D, Jech R, Růzicka E, Růzicka F, Liscák R, Vladyka V.

Cas Lek Cesk. 2011;150(4-5):223-8. Czech.